AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Stivarga has 0.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Stivarga (stivarga.com)
This is a digital ghost site that currently offers zero substance and serves only as a technical barrier. While it avoids the ‘hot air’ of marketing fluff, it fails every industry-specific requirement for transparency, authority, and clinical proof. The site is a pharmaceutical authority vacuum.
The technical team must immediately resolve the 403-error/bot-block to restore the site’s primary pharmaceutical content. Once restored, the homepage must be updated to include an H1 tag with clear, FDA-compliant indications for the product. Structured data, specifically MedicalWebPage or Drug schema, must be implemented to link to verified clinical trial data. Finally, the site must include a mandatory pharmacovigilance link for adverse event reporting to satisfy basic regulatory and industry trust standards.
The site exhibits zero industry-specific information density. The body substance ratio is 100% non-substantive for the pharma sector, as the text consists entirely of server-side error messaging regarding bot activity and IP addresses like 77.37.37.89. There are no H1 or H2 headings to provide structural context or value propositions. Every pharmaceutical specificity requirement, from clinical trial results to mechanism of action, is entirely absent, replaced by 286 characters of functional technical jargon.
Weak or disconnected schema makes your brand invisible in AI driven retrieval. Generate your Structured Data Audit and quantify the trust, visibility, and ranking loss caused by semantic gaps.
A significant functional drift exists between the meta_title ‘Site Maintenance’ and the clean_text which describes a ‘harmful activity’ block. While the title suggests a planned offline status, the actual page content indicates an active security firewall rejection. There is no messaging consistency because the primary signal for a pharmaceutical product is completely missing, leaving no clinical promise to be verified by sub-pages. This represents a total disconnect between the expected brand identity and the technical reality delivered.
Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.
Trust signals are non-existent, with a review_count of 0 and a proof_links_count of 0 across the available data. The site fails to meet any industry proof expectations, such as links to peer-reviewed studies or regulatory clearance numbers. Because no marketing claims are made, the trust_theatre_flag is false, yet the lack of a pharmacovigilance or adverse event reporting mechanism is a major red flag for a pharma domain.
The proof density is zero, as the ratio of verifiable evidence to unsubstantiated assertions cannot be calculated in the absence of assertions. However, against the industry proof expectations, the site fails on all counts: no FDA 510(k) numbers, no peer-reviewed citations, and no manufacturing quality certifications. The site provides 100% technical noise and 0% pharmaceutical proof.
To see how the methodology translates into real diagnostic output, review a full executive level analysis applied to a global fashion retailer. View the Mango Executive SEO Strategy for a concrete example of how structural gaps, semantic weaknesses, and conversion friction are surfaced in practice.
The content is a textbook example of a commodity fingerprint, as the text ‘Your bot have been rated as a harmful activity’ is a generic security template used by various web firewalls. It contains no unique pharmaceutical positioning or differentiated value proposition that could distinguish Stivarga from any other product. The value prop uniqueness score is maximized at 5 because this exact content could be found on any non-industry domain experiencing similar technical issues. No industry-specific jargon or value-prop cliches are present, simply because no marketing content exists.
There is a massive authority gap due to the lack of any schema_json or organizational identity. The site references no experts, medical professionals, or regulatory bodies, and the technical implementation—blocking legitimate audit crawlers—directly contradicts the expected transparency of a high-stakes pharmaceutical brand. No Person schema or sameAs links to official clinical resources (like ClinicalTrials.gov) are provided to establish a digital footprint of authority.
The site makes no explicit marketing performance claims, but there is a profound disconnect between its implicit purpose as a medical resource and its actual function as a dead-end technical error. The absence of a ‘Patient Resources’ or ‘Clinical Data’ section, which are standard fingerprints for this industry, creates a void where substance should be. The technical error code 0.921e1202 serves as the only ‘specific’ data point, which holds zero value for the target medical audience.
Medical Devices, Pharma & Biotech BS: Stivarga (stivarga.com)
The URL and meta-title indicate that this is the primary digital asset for Stivarga (regorafenib), a pharmaceutical product within the Biotech and Pharma industry. However, the available data shows a total mismatch between the expected professional medical resource and the actual content, which is a technical bot-blocking error page.
AI cannot build a coherent graph if the same page resolves into multiple identities. Explore the URL & Canonical Hygiene Technical Framework to understand how identity stability prevents duplicate embeddings and semantic drift.
“The score of 40 reflects a 'Moderate BS' level, driven primarily by the Information Density and Identity/Authority pillars. The site is penalized for its total lack of industry substance and its technical failure to represent a regulated pharmaceutical entity. It does not reach the 'Extreme BS' range only because it lacks active, deceptive marketing hyperbole.”
Analysis Disclosure & Source Attribution
Snapshot Date: June 19, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Stivarga to view the most current version of their content and see directly what the company offers.